Hydroxamic Acids

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 2358 Experts worldwide ranked by ideXlab platform

Hermann M Niemeyer - One of the best experts on this subject based on the ideXlab platform.

  • Hydroxamic Acids derived from 2 hydroxy 2h 1 4 benzoxazin 3 4h one key defense chemicals of cereals
    Journal of Agricultural and Food Chemistry, 2009
    Co-Authors: Hermann M Niemeyer
    Abstract:

    Many cereals accumulate Hydroxamic Acids derived from 2-hydroxy-2H-1,4-benzoxazin-3(4H)-one. These benzoxazinoid Hydroxamic Acids are involved in defense of maize against various lepidopteran pests, most notably the European corn borer, in defense of cereals against various aphid species, and in allelopathy affecting the growth of weeds associated with rye and wheat crops. The role of benzoxazinoid Hydroxamic Acids in defense against fungal infection is less clear and seems to depend on the nature of the interactions at the plant−fungus interface. Efficient use of benzoxazinoid Hydroxamic Acids as resistance factors has been limited by the inability to selectively increase their levels at the plant growth stage and the plant tissues where they are mostly needed for a given pest. Although the biosynthesis of benzoxazinoid Hydroxamic Acids has been elucidated, the genes and mechanisms controlling their differential expression in different plant tissues and along plant ontogeny remain to be unraveled.

  • Hydroxamic Acids derived from 2 hydroxy 2h 1 4 benzoxazin 3 4h one key defense chemicals of cereals
    Journal of Agricultural and Food Chemistry, 2009
    Co-Authors: Hermann M Niemeyer
    Abstract:

    Many cereals accumulate Hydroxamic Acids derived from 2-hydroxy-2H-1,4-benzoxazin-3(4H)-one. These benzoxazinoid Hydroxamic Acids are involved in defense of maize against various lepidopteran pests...

Bhubaneswar Mandal - One of the best experts on this subject based on the ideXlab platform.

Jiwang Chern - One of the best experts on this subject based on the ideXlab platform.

  • quinazolin 2 4 dione based Hydroxamic Acids as selective histone deacetylase 6 inhibitors for treatment of non small cell lung cancer
    Journal of Medicinal Chemistry, 2019
    Co-Authors: Chaowu Yu, Peiyun Hung, Huiting Yang, Yihsun Ho, Yisheng Cheng, Jiwang Chern
    Abstract:

    We designed and synthesized quinazolin-2,4-dione-based Hydroxamic Acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, 3d (IC50, 4 nM, HDAC6; IC50 > 10 μM, HDAC1), substantially increased acetylation of α-tubulin instead of histones in the lung cancer cell line, LL2. Paclitaxel in combination with 3d had a synergistic anticancer effect on reduction of programmed death-ligand 1 expression in LL/2 cells. When given orally, 3d was mainly found to locate in the liver and lungs, at a concentration 18- to 70-fold greater, respectively, than in plasma. As an orally active HDAC6 inhibitor, 3d (20 mg/kg) potentiated paclitaxel antitumor activity (percentage tumor growth inhibition, 67.5%) in a xenograft syngeneic non-small cell lung cancer mouse model.

  • Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase‑6 Inhibitors for Treatment of Non-Small Cell Lung Cancer
    2018
    Co-Authors: Peiyun Hung, Huiting Yang, Yisheng Cheng, Hsing-yi Lai, Jiwang Chern
    Abstract:

    We designed and synthesized quinazolin-2,4-dione-based Hydroxamic Acids to serve as selective competitive inhibitors of histone deacetylase-6 (HDAC6). The most potent and selective compound, 3d (IC50, 4 nM, HDAC6; IC50 > 10 μM, HDAC1), substantially increased acetylation of α-tubulin instead of histones in the lung cancer cell line, LL2. Paclitaxel in combination with 3d had a synergistic anticancer effect on reduction of programmed death-ligand 1 expression in LL/2 cells. When given orally, 3d was mainly found to locate in the liver and lungs, at a concentration 18- to 70-fold greater, respectively, than in plasma. As an orally active HDAC6 inhibitor, 3d (20 mg/kg) potentiated paclitaxel antitumor activity (percentage tumor growth inhibition, 67.5%) in a xenograft syngeneic non-small cell lung cancer mouse model

Julia Lloyd - One of the best experts on this subject based on the ideXlab platform.

Kishore Thalluri - One of the best experts on this subject based on the ideXlab platform.